Position in GRAL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$271,851
+$180,326 QoQ
Shares Held
3,982
+124.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#187
of 371 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026State of Wyoming holds $9,049,964 across 23 Diagnostics & Research names. GRAL ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
22,228 | $3,861,225 | |
| 2 | SHC |
Sotera Health Co
|
56,651 | $1,005,555 | |
| 3 | MYGN |
Myriad Genetics Inc
|
107,783 | $615,440 | |
| 4 | GH |
Guardant Health, Inc.
|
2,620 | $393,078 | |
| 5 | VCYT |
Veracyte, Inc.
|
6,192 | $363,656 | |
| 6 | NEO |
Neogenomics Inc
|
19,811 | $289,042 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
3,982 | $271,851 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,196 | $271,240 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,851 | 3,982 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $91,525 | 1,771 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $355,112 | 4,149 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $175,675 | 2,971 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $376,240 | 7,317 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $2,181,320 | 85,408 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $923,683 | 51,747 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $334,120 | 24,282 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,988 | 780 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||